{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Xylènes : Questions médicales les plus fréquentes",
"headline": "Xylènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Xylènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-07",
"dateModified": "2025-05-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Xylènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Xylènes",
"alternateName": "Xylenes",
"code": {
"@type": "MedicalCode",
"code": "D014992",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Ryan P Lively",
"url": "https://questionsmedicales.fr/author/Ryan%20P%20Lively",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, USA. ryan.lively@chbe.gatech.edu."
}
},
{
"@type": "Person",
"name": "Jing Li",
"url": "https://questionsmedicales.fr/author/Jing%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, NJ 08854, USA."
}
},
{
"@type": "Person",
"name": "Xiao Zhang",
"url": "https://questionsmedicales.fr/author/Xiao%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Energy and Environmental Engineering, Key Laboratory of Clean Energy Utilization and Pollutant Control in Tianjin, Hebei University of Technology, China."
}
},
{
"@type": "Person",
"name": "Yao Ma",
"url": "https://questionsmedicales.fr/author/Yao%20Ma",
"affiliation": {
"@type": "Organization",
"name": "School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Atlanta, GA 30332, USA. ryan.lively@chbe.gatech.edu."
}
},
{
"@type": "Person",
"name": "Jian Zhang",
"url": "https://questionsmedicales.fr/author/Jian%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Hoffmann Institute of Advanced Materials, Shenzhen Polytechnic, 7098 Liuxian Blvd., Nanshan District, Shenzhen, 518055, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Validation of immunofluorescence analysis of blood smears in patients with inherited platelet disorders.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36732160",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2022.12.031"
}
},
{
"@type": "ScholarlyArticle",
"name": "The rate of platelet activation determines thrombus size and structure at arterial shear.",
"datePublished": "2023-04-19",
"url": "https://questionsmedicales.fr/article/37085037",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.03.044"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet inhibition by low-dose aspirin is not influenced by body mass or weight.",
"datePublished": "2022-06-29",
"url": "https://questionsmedicales.fr/article/35768902",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09537104.2022.2087868"
}
},
{
"@type": "ScholarlyArticle",
"name": "Platelet dysfunction persists after trauma despite balanced blood product resuscitation.",
"datePublished": "2022-10-22",
"url": "https://questionsmedicales.fr/article/36280503",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.surg.2022.09.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Time from blood draw to multiple electrode aggregometry and association with platelet reactivity.",
"datePublished": "2022-11-08",
"url": "https://questionsmedicales.fr/article/36344849",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11239-022-02720-7"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Xylènes",
"item": "https://questionsmedicales.fr/mesh/D014992"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Xylènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Xylènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Xylènes",
"description": "Comment diagnostiquer une intoxication aux xylènes ?\nQuels tests sont utilisés pour évaluer l'exposition aux xylènes ?\nQuels symptômes indiquent une exposition aux xylènes ?\nLes xylènes peuvent-ils être détectés dans l'air ?\nQuelle est la méthode de diagnostic la plus courante ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Xylènes",
"description": "Quels sont les symptômes d'une intoxication aiguë aux xylènes ?\nLes xylènes provoquent-ils des effets à long terme ?\nComment les xylènes affectent-ils le système nerveux ?\nLes irritations cutanées sont-elles liées aux xylènes ?\nQuels signes indiquent une exposition chronique aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Xylènes",
"description": "Comment prévenir l'exposition aux xylènes ?\nLes xylènes sont-ils présents dans des produits courants ?\nQuelles mesures de sécurité doivent être prises en milieu professionnel ?\nLes fumeurs sont-ils plus à risque d'exposition aux xylènes ?\nLes enfants sont-ils plus sensibles aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Xylènes",
"description": "Quel est le traitement principal en cas d'intoxication aux xylènes ?\nDes antidotes existent-ils pour les xylènes ?\nComment traiter les irritations cutanées causées par les xylènes ?\nLes soins médicaux sont-ils nécessaires pour une exposition aux xylènes ?\nQuels traitements sont utilisés pour les effets neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Xylènes",
"description": "Quelles complications peuvent survenir après une exposition aux xylènes ?\nLes xylènes peuvent-ils causer des cancers ?\nComment les xylènes affectent-ils la fonction hépatique ?\nLes effets des xylènes sont-ils réversibles ?\nQuelles sont les conséquences d'une exposition chronique ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Xylènes",
"description": "Qui est le plus à risque d'exposition aux xylènes ?\nLes personnes vivant près d'industries sont-elles à risque ?\nLes femmes enceintes sont-elles plus vulnérables ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?\nLes fumeurs sont-ils plus exposés aux xylènes ?",
"url": "https://questionsmedicales.fr/mesh/D014992?mesh_terms=Platelet+Function+Tests&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux xylènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins pour mesurer les niveaux de xylènes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'exposition aux xylènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les xylènes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux xylènes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des vertiges et des irritations des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Les xylènes peuvent-ils être détectés dans l'air ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des échantillons d'air peuvent être analysés pour mesurer la concentration de xylènes."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de diagnostic la plus courante ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'interrogatoire clinique et l'examen physique sont essentiels pour le diagnostic initial."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication aiguë aux xylènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements, des maux de tête et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les xylènes provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Comment les xylènes affectent-ils le système nerveux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des symptômes neurologiques tels que des vertiges et des troubles de la coordination."
}
},
{
"@type": "Question",
"name": "Les irritations cutanées sont-elles liées aux xylènes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le contact avec les xylènes peut causer des irritations cutanées et des dermatites."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une exposition chronique aux xylènes ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles cognitifs, des maux de tête fréquents et des problèmes respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux xylènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et travailler dans des zones bien ventilées."
}
},
{
"@type": "Question",
"name": "Les xylènes sont-ils présents dans des produits courants ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils se trouvent dans des produits comme les peintures, les vernis et les nettoyants."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être prises en milieu professionnel ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des protocoles de sécurité, des formations et des équipements de protection."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus à risque d'exposition aux xylènes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter la vulnérabilité aux effets nocifs des xylènes."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus sensibles aux xylènes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux xylènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la personne de l'exposition et à administrer de l'oxygène si nécessaire."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les xylènes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les xylènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de laver la zone affectée avec de l'eau et du savon, et d'appliquer une crème apaisante."
}
},
{
"@type": "Question",
"name": "Les soins médicaux sont-ils nécessaires pour une exposition aux xylènes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale est recommandée pour surveiller les symptômes et les complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont utilisés pour les effets neurologiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des thérapies de réhabilitation peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux xylènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles respiratoires, neurologiques et des problèmes hépatiques."
}
},
{
"@type": "Question",
"name": "Les xylènes peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre l'exposition prolongée aux xylènes et certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les xylènes affectent-ils la fonction hépatique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des lésions hépatiques et des troubles de la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Les effets des xylènes sont-ils réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres, notamment neurologiques, peuvent être permanents."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une exposition chronique ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition chronique peut entraîner des troubles cognitifs, des problèmes respiratoires et des cancers."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux xylènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique, la peinture et le nettoyage sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les personnes vivant près d'industries sont-elles à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être exposées à des niveaux plus élevés de xylènes dans l'air ambiant."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux xylènes peut affecter le développement fœtal et la santé de la mère."
}
},
{
"@type": "Question",
"name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, celles ayant des problèmes respiratoires ou neurologiques préexistants sont plus vulnérables."
}
},
{
"@type": "Question",
"name": "Les fumeurs sont-ils plus exposés aux xylènes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter l'absorption des xylènes et leurs effets nocifs."
}
}
]
}
]
}
Inherited platelet disorders (IPDs) are rare diseases characterized by reduced blood platelet counts and/or impaired platelet function. Recognizing IPDs is advisable but often challenging. The diagnos...
The aim of the present study was to validate immunofluorescence microscopy as a screening tool for IPDs in comparison with genetic screening....
We performed a blinded comparison between the diagnosis made using immunofluorescence microscopy on blood smears and genetic findings in a cohort of 43 families affected with 20 different genetically ...
Immunofluorescence correctly predicted the underlying IPD in the vast majority of patients with 1 of 9 IPDs for which the typical morphologic pattern is known. Thirty of the 43 enrolled families (70%)...
Immunofluorescence microscopy on blood smears is an effective screening tool for 9 forms of IPD, which include the most frequent forms of inherited thrombocytopenia. Using this approach, typical chang...
The response of platelets to activating stimuli and pharmaceutical agents varies greatly within the normal population. Current platelet function tests are used to measure end-point levels of platelet ...
To identify variability, to agonists and among individuals, in platelet activation kinetics and assess the impact of this on thrombus formation....
We have developed a bespoke real-time flow cytometry assay and analysis package to measure the rate of platelet activation over time using 2 parameters of platelet activation, fibrinogen binding and P...
The rate of platelet activation varied considerably within the normal population but did not correlate with maximal platelet activation, demonstrating that platelet activation rate is a separate and n...
For the first time, we have shown that platelet response rate corresponds to thrombus size and structure, wherein faster responders form larger, more densely packed thrombi at arterial, but crucially ...
Aspirin's clinical efficacy may be influenced by body weight and mass. Although inadequate platelet inhibition by aspirin is suggested as responsible, evidence for this in non-diabetic patients is spa...
Platelet activation and aggregation are critical to the initiation of hemostasis after trauma with hemorrhage. Platelet dysfunction is a well-recognized phenomenon contributing to trauma-induced coagu...
A retrospective secondary cohort study of platelet count and function was performed using samples from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial. Platelet characteristics were ...
In total, 680 patients were included for analysis. Platelet counts were significantly lower from baseline to 72 hours after hospital admission with further 1.3 to 2-fold reductions noted in nonsurvivo...
Platelet aggregability recovers 12 hours after injury independent of worsening thrombocytopenia. Failure of platelet function to recover portends a poor prognosis....
Results from multiple electrode aggregometry (MEA) may vary according to pre-analytic factors. This study aimed to analyze the association of time from blood draw to MEA in patients undergoing percuta...
Evidence surrounding P2Y12 platelet reactivity units (PRU) impact on bleeding outcomes in patients undergoing coronary artery bypass is varied. This study sought to assess whether on-pump CABG procedu...
This retrospective cohort study compared those with a PRU level ≤237 (low PRU group) to >237 (high PRU group). The primary outcome assessed massive or severe bleeding in accordance with universal defi...
A total of 69 patients were included, 47 in the low and 22 in the high PRU groups. Patients were a median (IQR) 66 (62-74) years and 84.1% (N.=58) were male. Most patients received clopidogrel prior t...
This study determined that low preoperative P2Y12 PRU levels may influence moderate bleeding in patients undergoing cardiac surgery, but not massive or severe bleeding....
Despite Antiplatelet therapy (APT), cardiovascular patients undergoing revascularisation remain at high risk for thrombotic events. Individual response to APT varies substantially, resulting in insuff...
To investigate residual platelet reactivity variability over time in individual patients undergoing carotid endarterectomy (CEA) treated with clopidogrel....
Platelet reactivity was determined in patients undergoing CEA in a prospective, single-centre, observational study using the VerifyNow (change in turbidity from ADP-induced binding to fibrinogen-coate...
Between December 2017 and November 2019, 50 patients undergoing CEA were included. Platelet reactivity measured with the VerifyNow (p = < .001) and VASP (p = .029) changed over time, while the PACT di...
In patients undergoing CEA, perioperative platelet reactivity measurements fluctuate over time with little agreement between platelet reactivity assays. Consequently, HTPR status of individual patient...
Heparin-induced thrombocytopenia (HIT), a severe autoimmune disorder, occurs in patients undergoing heparin therapy. The presence of platelet-activating antibodies against platelet factor 4/Heparin in...
High-on-treatment platelet reactivity (HTPR) has been established as a predictor of major adverse cardiovascular events (MACE) in patients undergoing percutaneous coronary interventions on dual antipl...
All consecutive patients treated with CAS in a single institution were enrolled in a prospective clinical study. HTPR was evaluated with 5 different laboratory assays carried out just before CAS. MACE...
A total of 300 patients were enrolled in the study, and eight were then excluded because blood samples resulted unsuitable for the laboratory testing or CAS aborted for technical problems. Median foll...
HTPR to three different assays (mainly to VASP + PFA P2Y+ VerifyNow) in patients on DAPT after CAS has predictive value for subsequent MACE. Prospective studies to assess whether platelet function tes...
Cigarette smoking is a potent modifiable risk factor for coronary artery disease (CAD). However, little is known about alterations to prothrombotic state and platelet reactivity early after smoking ce...
We investigated alterations to platelet reactivity, coagulation and markers of platelet, endothelial, inflammatory and coagulation activation in clopidogrel-treated patients with CAD after PCI before ...
Smoking patients aged 18 years or older at least 30 days after PCI were recruited and encouraged to quit the habit. At baseline and at 30 days, we measured platelet reactivity with VerifyNow system, t...
Among 117 patients, 84 patients (72%) at a median age of 60.5 years (40 [interquartile range 30-47] pack-years) completed a 30-day follow-up. At day 30, 30 (35.7%) patients stopped smoking with cotini...
After smoking cessation in CAD patients following PCI an increase in platelet reactivity and a decrease in P-selectin levels were observed. The risk of thrombotic complications post PCI might be parad...